Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094

Ribonucleoside analog inhibitors (rNAI) target the hepatitis C virus (HCV) RNA-dependent RNA polymerase nonstructural protein 5B (NS5B) and cause RNA chain termination. Here, we expand our studies on β-d-2′-C-methyl-2,6-diaminopurine-ribonucleotide (DAPN) phosphoramidate prodrug 1 (PD1) as a novel i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Ehteshami, Maryam, Tao, Sijia, Ozturk, Tugba, Zhou, Longhu, Cho, Jong Hyun, Zhang, Hongwang, Amiralaei, Sheida, Shelton, Jadd R., Lu, Xiao, Khalil, Ahmed, Domaoal, Robert A., Stanton, Richard A., Suesserman, Justin E., Lin, Biing, Lee, Sam S., Amblard, Franck, Whitaker, Tony, Coats, Steven J., Schinazi, Raymond F.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4958185/
https://ncbi.nlm.nih.gov/pubmed/27216050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00318-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados